China Meheco Group Co., Ltd. (SHA:600056)
10.78
-0.05 (-0.46%)
At close: Feb 6, 2026
China Meheco Group Revenue
China Meheco Group had revenue of 8.82B CNY in the quarter ending September 30, 2025, with 3.67% growth. This brings the company's revenue in the last twelve months to 33.23B, down -7.27% year-over-year. In the year 2024, China Meheco Group had annual revenue of 34.15B, down -12.04%.
Revenue (ttm)
33.23B
Revenue Growth
-7.27%
P/S Ratio
0.49
Revenue / Employee
3.97M
Employees
8,368
Market Cap
16.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 34.15B | -4.68B | -12.04% |
| Dec 31, 2023 | 38.82B | 1.23B | 3.28% |
| Dec 31, 2022 | 37.59B | 1.36B | 3.75% |
| Dec 31, 2021 | 36.23B | -3.08B | -7.83% |
| Dec 31, 2020 | 39.31B | 4.03B | 11.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Pharmaceuticals Holding | 280.69B |
| Jointown Pharmaceutical Group | 157.71B |
| C.Q. Pharmaceutical Holding | 83.08B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 77.54B |
| China National Accord Medicines Corporation | 73.04B |
| China National Medicines Corporation | 51.95B |
| Guangxi LiuYao Group | 20.95B |
| Liaoning Cheng Da | 11.12B |